Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

The European Union Allocates Six Million Euros to Study Prevention Strategies Tumors Caused by HPV

Published: Tuesday, November 05, 2013
Last Updated: Tuesday, November 05, 2013
Bookmark and Share
The human papillomavirus (HPV) is responsible for cervical cancer and is behind a significant percentage of other tumors such as vulva , vagina, penis, anus, and oropharynx.

It is estimated that, in Europe , every year 30,000 women die as a result of cervical cancer, especially in the Eastern countries , where screening programs are not consolidated.

The consortium CoheaHr wants to provide scientific evidence for the clinical effectiveness and cost - effectiveness of different strategies to prevent cervical cancer throughout the European Union. To assess strategies focus on screening for HPV detection and vaccination. Specifically, the consortium conducted four clinical trials:

•    Compare the results of sampling for HPV testing when performed by the patient herself and when you get a health care professional, and their possible implementation as a method to increase screening coverage.
•    To determine the subsequent most appropriate time intervals and the use of HPV screening test for subsequent monitoring of :
      o    Women in age to start screening, vaccinated  during adolescence
      o    Young women vaccinated two years before the start of screening.
•    To assess the feasibility and acceptance of the HPV vaccine by the women entering the routine screening between 25-45 years.

The results of the different components will be incorporated into transmission models, economic and impact made by the consortium to make projections of different preventive interventions.

The consortium is committed to producing systematic reviews that allow summarizing the evidence generated in the medical literature and contribute to the dissemination of research results.

CoheaHr consortium with the participation of twelve partners from eleven countries: Amsterdam, Barcelona, Tampere, London, Turin, Stockholm, Brussels, Ljubljana, Lyon, Copenhagen, Reims and Wolfsburg. The Research Program in Cancer Epidemiology ICO lead two areas of work, the study of acceptance of the vaccine in women aged 25-45 years and scientific dissemination activities.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!